Detection and Characterization of Human Serum Antibodies Against Avian Hepatitis E Virus

ZHANG Hong-xia,JING Sheng-tao,ZHOU En-min,SUN Pei-ming,DONG Shi-wei,LI Yan-ju

2009-01-01

Abstract:Objective: To detect and characterize human serum antibodies against avian hepatitis E virus(HEV).Methods:Truncated recombinant avian HEV ORF2,designated ORF2-1,with a sequence between 339 and 570 of C terminal of ORF2 was produced in E coli.The synthetic peptides,named Pep-8 and Pepp-9,with aa sequences between 473 and 492 and between 477 and 492,respectively,were synthesized.ORF2-1 antigen was used in an indirect ELISA to screen 7234 human serum samples collected from young and healthy individuals.The ORF2-1 positive serum samples were first confirmed by the Western blot analysis and further characterized by direct binding to Pep-8 and Pep-9 antigen in an indirect ELISA.Results:From 7234 human serum samples screened against avian HEV ORF2-1 by the indirect ELISA,66 were detected positive and confirmed by the Western blot assay.The positive rate of human serum antibodies against avian HEV ORF2 was 0.91%.Further characterization of 66 ORF2-1 positive samples demonstrated that 19 samples were positive for Pep-8,17 positive for Pep-9 and 8 positive for both Pep-8 and Pep-9 with the specific anti-avian HEV antibody rate of 42.4%.These avian HEV ORF2 antibody positive human serum samples were from 21 female and 7 male young and healthy individuals with the ratio of female to male of 3:1.Conclusion:The results presented in this study demonstrated that sera from young and healthy individuals contained antibodies specific against avian HEV ORF2 antigen with the positive rate of 0.387%,suggesting that avian HEV could infect humans.The anti-avian HEV ORF2 positive rate of female and male was 3:1 indicating female has higher potential of being infected with avian HEV than male like that in human HEV infection.